PROX1 is a predictor of survival for gliomas WHO grade II

Detecting chromosomal alterations at 1p and 19q by FISH and DNA fragment analysis – a comparative study in human gliomas

(2011) H. Broholm et al.   CLINICAL NEUROPATHOLOGY

Seizures and the Natural History of World Health Organization Grade II Gliomas: A Review

(2011) Anja Smits et al.   NEUROSURGERY

The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations

(2010) Andreas Von Deimling et al.   BRAIN PATHOLOGY

Management of Low-Grade Glioma

(2010) Nader Pouratian et al.   Current Neurology and Neuroscience Reports

Surgery of low-grade gliomas: towards a ‘functional neurooncology’

(2010) Hugues Duffau   CURRENT OPINION IN ONCOLOGY

Guidelines on management of low-grade gliomas: report of an EFNS-EANO* Task Force

(2010) R. Soffietti et al.   EUROPEAN JOURNAL OF NEUROLOGY

Expression of PROX1 Is a Common Feature of High-Grade Malignant Astrocytic Gliomas

(2010) Tamador Elsir et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Monoclonal antibody specific for IDH1 R132H mutation

(2009) David Capper et al.   ACTA NEUROPATHOLOGICA

Mutant Metabolic Enzymes Are at the Origin of Gliomas

(2009) H. Yan et al.   CANCER RESEARCH

Current concepts in the evaluation and management of WHO grade II gliomas

(2009) Joseph M. Piepmeier   JOURNAL OF NEURO-ONCOLOGY

Transcription Factor PROX1 Induces Colon Cancer Progression by Promoting the Transition from Benign to Highly Dysplastic Phenotype

(2008) Tatiana V. Petrova et al.   CANCER CELL

Prox1 regulates a transitory state for interneuron neurogenesis in the spinal cord

(2008) Kamana Mishra et al.   DEVELOPMENTAL DYNAMICS

Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation

(2008) Jeremy Rees et al.   EUROPEAN JOURNAL OF RADIOLOGY

Prognostic significance of imaging contrast enhancement for WHO grade II gliomas

(2008) Johan Pallud et al.   NEURO-ONCOLOGY